" class="no-js "lang="en-US"> Alain Huriez Archives - Medtech Alert
Friday, April 12, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Thabor Therapeutics Appoints Jérémie Mariau as Ceo

Thabor Therapeutics, a company developing an innovative treatment for patients living with chronic mucosal inflammatory […]

AdBio Partners Welcomes Inserm Transfert As Investor in Second Fund – AFB Fund II

AdBio partners, an AMF-regulated (the French financial market authority) investment company dedicated to life sciences, […]

Univercells Acquires SynHelix, Entering into Synthetic Biology and the Race to Next-generation DNA Synthesis

Univercells S.A. (Univercells) today announces its acquisition of SynHelix, a biotechnology company that aims to debottleneck […]

Advent France Biotechnology Launches its Second Fund with a First Close at €86M ($102M)

Advent France Biotechnology (AFB), an AMF-regulated investment company dedicated to life sciences, today announces the […]

Advent France Biotechnology (AFB) Appoints Sidonie Fabre as CFO

Advent France Biotechnology (AFB), an AMF-regulated investment company dedicated to life sciences, today announces the […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more